The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. 2003

Woong-Kyung Suh, and Beata U Gajewska, and Hitoshi Okada, and Matthew A Gronski, and Edward M Bertram, and Wojciech Dawicki, and Gordon S Duncan, and Jacob Bukczynski, and Suzanne Plyte, and Andrew Elia, and Andrew Wakeham, and Annick Itie, and Stephen Chung, and Joan Da Costa, and Sudha Arya, and Tom Horan, and Pauline Campbell, and Kevin Gaida, and Pamela S Ohashi, and Tania H Watts, and Steven K Yoshinaga, and Mark R Bray, and Manel Jordana, and Tak W Mak
Advanced Medical Discovery Institute, Ontario Cancer Institute, and Department of Medical Biophysics, University of Toronto, 620 University Avenue, Toronto, Ontario M5G 2C1, Canada. wsuh@uhnres.utoronto.ca

We investigated the in vivo function of the B7 family member B7-H3 (also known as B7RP-2) by gene targeting. B7-H3 inhibited T cell proliferation mediated by antibody to T cell receptor or allogeneic antigen-presenting cells. B7-H3-deficient mice developed more severe airway inflammation than did wild-type mice in conditions in which T helper cells differentiated toward type 1 (T(H)1) rather than type 2 (T(H)2). B7-H3 expression was consistently enhanced by interferon-gamma but suppressed by interleukin 4 in dendritic cells. B7-H3-deficient mice developed experimental autoimmune encephalomyelitis several days earlier than their wild-type littermates, and accumulated higher concentrations of autoantibodies to DNA. Thus, B7-H3 is a negative regulator that preferentially affects T(H)1 responses.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008217 Lymphocytic choriomeningitis virus The type species of ARENAVIRUS, part of the Old World Arenaviruses (ARENAVIRUSES, OLD WORLD), producing a silent infection in house and laboratory mice. In humans, infection with LCMV can be inapparent, or can present with an influenza-like illness, a benign aseptic meningitis, or a severe meningoencephalomyelitis. The virus can also infect monkeys, dogs, field mice, guinea pigs, and hamsters, the latter an epidemiologically important host. LCM Viruses,LCMV,LCM Virus,Lymphocytic choriomeningitis viruses
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009975 Orthomyxoviridae A family of RNA viruses causing INFLUENZA and other respiratory diseases. Orthomyxoviridae includes INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; INFLUENZAVIRUS D; ISAVIRUS; and THOGOTOVIRUS. Influenza Viruses,Myxoviruses,Orthomyxoviruses,Influenza Virus,Myxovirus,Orthomyxovirus
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D004681 Encephalomyelitis, Autoimmune, Experimental An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5) Autoimmune Encephalomyelitis, Experimental,Encephalomyelitis, Allergic,Encephalomyelitis, Experimental Autoimmune,Allergic Encephalomyelitis,Allergic Encephalomyelitis, Experimental,Autoimmune Experimental Encephalomyelitis,Experimental Allergic Encephalomyelitis,Experimental Autoimmune Encephalomyelitis,Encephalomyelitis, Autoimmune Experimental,Encephalomyelitis, Experimental Allergic,Experimental Allergic Encephalomyelitides,Experimental Encephalomyelitis, Autoimmune
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Woong-Kyung Suh, and Beata U Gajewska, and Hitoshi Okada, and Matthew A Gronski, and Edward M Bertram, and Wojciech Dawicki, and Gordon S Duncan, and Jacob Bukczynski, and Suzanne Plyte, and Andrew Elia, and Andrew Wakeham, and Annick Itie, and Stephen Chung, and Joan Da Costa, and Sudha Arya, and Tom Horan, and Pauline Campbell, and Kevin Gaida, and Pamela S Ohashi, and Tania H Watts, and Steven K Yoshinaga, and Mark R Bray, and Manel Jordana, and Tak W Mak
May 2013, Structure (London, England : 1993),
Woong-Kyung Suh, and Beata U Gajewska, and Hitoshi Okada, and Matthew A Gronski, and Edward M Bertram, and Wojciech Dawicki, and Gordon S Duncan, and Jacob Bukczynski, and Suzanne Plyte, and Andrew Elia, and Andrew Wakeham, and Annick Itie, and Stephen Chung, and Joan Da Costa, and Sudha Arya, and Tom Horan, and Pauline Campbell, and Kevin Gaida, and Pamela S Ohashi, and Tania H Watts, and Steven K Yoshinaga, and Mark R Bray, and Manel Jordana, and Tak W Mak
October 1999, The Journal of experimental medicine,
Woong-Kyung Suh, and Beata U Gajewska, and Hitoshi Okada, and Matthew A Gronski, and Edward M Bertram, and Wojciech Dawicki, and Gordon S Duncan, and Jacob Bukczynski, and Suzanne Plyte, and Andrew Elia, and Andrew Wakeham, and Annick Itie, and Stephen Chung, and Joan Da Costa, and Sudha Arya, and Tom Horan, and Pauline Campbell, and Kevin Gaida, and Pamela S Ohashi, and Tania H Watts, and Steven K Yoshinaga, and Mark R Bray, and Manel Jordana, and Tak W Mak
December 2008, Immunology,
Woong-Kyung Suh, and Beata U Gajewska, and Hitoshi Okada, and Matthew A Gronski, and Edward M Bertram, and Wojciech Dawicki, and Gordon S Duncan, and Jacob Bukczynski, and Suzanne Plyte, and Andrew Elia, and Andrew Wakeham, and Annick Itie, and Stephen Chung, and Joan Da Costa, and Sudha Arya, and Tom Horan, and Pauline Campbell, and Kevin Gaida, and Pamela S Ohashi, and Tania H Watts, and Steven K Yoshinaga, and Mark R Bray, and Manel Jordana, and Tak W Mak
March 2015, Oncology letters,
Woong-Kyung Suh, and Beata U Gajewska, and Hitoshi Okada, and Matthew A Gronski, and Edward M Bertram, and Wojciech Dawicki, and Gordon S Duncan, and Jacob Bukczynski, and Suzanne Plyte, and Andrew Elia, and Andrew Wakeham, and Annick Itie, and Stephen Chung, and Joan Da Costa, and Sudha Arya, and Tom Horan, and Pauline Campbell, and Kevin Gaida, and Pamela S Ohashi, and Tania H Watts, and Steven K Yoshinaga, and Mark R Bray, and Manel Jordana, and Tak W Mak
October 2018, International journal of molecular sciences,
Woong-Kyung Suh, and Beata U Gajewska, and Hitoshi Okada, and Matthew A Gronski, and Edward M Bertram, and Wojciech Dawicki, and Gordon S Duncan, and Jacob Bukczynski, and Suzanne Plyte, and Andrew Elia, and Andrew Wakeham, and Annick Itie, and Stephen Chung, and Joan Da Costa, and Sudha Arya, and Tom Horan, and Pauline Campbell, and Kevin Gaida, and Pamela S Ohashi, and Tania H Watts, and Steven K Yoshinaga, and Mark R Bray, and Manel Jordana, and Tak W Mak
January 2004, Journal of immunology (Baltimore, Md. : 1950),
Woong-Kyung Suh, and Beata U Gajewska, and Hitoshi Okada, and Matthew A Gronski, and Edward M Bertram, and Wojciech Dawicki, and Gordon S Duncan, and Jacob Bukczynski, and Suzanne Plyte, and Andrew Elia, and Andrew Wakeham, and Annick Itie, and Stephen Chung, and Joan Da Costa, and Sudha Arya, and Tom Horan, and Pauline Campbell, and Kevin Gaida, and Pamela S Ohashi, and Tania H Watts, and Steven K Yoshinaga, and Mark R Bray, and Manel Jordana, and Tak W Mak
December 2003, Zhonghua yi xue za zhi,
Woong-Kyung Suh, and Beata U Gajewska, and Hitoshi Okada, and Matthew A Gronski, and Edward M Bertram, and Wojciech Dawicki, and Gordon S Duncan, and Jacob Bukczynski, and Suzanne Plyte, and Andrew Elia, and Andrew Wakeham, and Annick Itie, and Stephen Chung, and Joan Da Costa, and Sudha Arya, and Tom Horan, and Pauline Campbell, and Kevin Gaida, and Pamela S Ohashi, and Tania H Watts, and Steven K Yoshinaga, and Mark R Bray, and Manel Jordana, and Tak W Mak
April 2004, Allergy,
Woong-Kyung Suh, and Beata U Gajewska, and Hitoshi Okada, and Matthew A Gronski, and Edward M Bertram, and Wojciech Dawicki, and Gordon S Duncan, and Jacob Bukczynski, and Suzanne Plyte, and Andrew Elia, and Andrew Wakeham, and Annick Itie, and Stephen Chung, and Joan Da Costa, and Sudha Arya, and Tom Horan, and Pauline Campbell, and Kevin Gaida, and Pamela S Ohashi, and Tania H Watts, and Steven K Yoshinaga, and Mark R Bray, and Manel Jordana, and Tak W Mak
December 2007, Journal of leukocyte biology,
Woong-Kyung Suh, and Beata U Gajewska, and Hitoshi Okada, and Matthew A Gronski, and Edward M Bertram, and Wojciech Dawicki, and Gordon S Duncan, and Jacob Bukczynski, and Suzanne Plyte, and Andrew Elia, and Andrew Wakeham, and Annick Itie, and Stephen Chung, and Joan Da Costa, and Sudha Arya, and Tom Horan, and Pauline Campbell, and Kevin Gaida, and Pamela S Ohashi, and Tania H Watts, and Steven K Yoshinaga, and Mark R Bray, and Manel Jordana, and Tak W Mak
January 2007, Immunology letters,
Copied contents to your clipboard!